U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07488234) titled 'Impact of a Glaucoma Awareness Program on Treatment Adherence' on Dec. 30, 2025.
Brief Summary: Glaucoma is a leading cause of irreversible blindness worldwide, with a higher burden in low- and middle-income countries such as Nepal, where public awareness and treatment adherence remain poor. Lifelong adherence to treatment is important to prevent disease progression but still non adherence remains common.
This is a mixed method study which aims to evaluate the effectiveness of structured glaucoma awareness program in improving treatment adherence among glaucoma patients attending a tertiary eye hospital in Nepal. Quantitative asse...